The diagnostic concordance between micro real-time PCR and Lowenstein Jensen (LJ) media assays for pulmonary tuberculosis detection with associated clinical characteristics

Author:

Khutade Kalpesh1ORCID,Patil Samiksha1ORCID,Shah Harshada1ORCID,Patel Hirenkumar1ORCID

Affiliation:

1. Vedantaa Institute of Medical Sciences, Palghar, Maharashtra, India

Abstract

Tuberculosis (TB) is an infectious disease that can affect various parts of the body, with lung infections being the most common cause. In this study, drug susceptibility testing (DST) using LJ media was compared to Truenat testing to detect rifampicin resistance in sputum smear-positive cases with related clinical characteristics. The Vedantaa Institute of Medical Sciences conducted a laboratory-based study from July 2023 to December 2023, enrolling 102 clinical isolates. Sputum smears with acid-fast bacilli were cultured in LJ medium, isolated, and grown with rifampicin for resistance observation and a correlation with Truenat.The study found that individuals aged 21–30 had the highest prevalence of TB. The highest detection ratio was shown in the Below Poverty Line (BPL) at 84.2%, and Rifampicin (RIF) resistance was detected at 75%. A TB positive ratio of 68.4% were found to be both alcoholic and smoker population and 42.1% were found to have asthma and liver disease, no Rifampicin (RIF) resistance was detected in both the population. In HIV patients 50% RIF resistance was detected. MTB coinfections were observed in 68.4% of pneumonia patients. The LJ culture test had 95% sensitivity and 100% specificity for MTB detection, while the Truenat test had 100% sensitivity and 100% specificity for both MTB testing and MTB/RIF resistance detection.Demographic, clinical, and social variables, including alcoholics and smokers, asthma and liver disease, hypertension, diabetes, and co-infection with pneumonia, were the main factors for pulmonary tuberculosis patients. Micro-real-time PCR has higher clinical sensitivity for MTB detection, while conventional tests predict rifampicin resistance.

Publisher

IP Innovative Publication Pvt Ltd

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3